Till startsida
University of Gothenburg
Sitemap
To content Read more about how we use cookies on gu.se

Ethical approval for new Phase I study

News: Jan 13, 2014

The Regional Ethical Review Board in Göteborg approved our forthcoming Phase I study with i.p. 211At-Rebmab200 (a humanized whole IgG version of the MX35 antibody) on 2013-12-19. We now continue approaching the Swedish Medical Products Agency in Uppsala and will meet with them on 14th of February

BY:

Page Manager: Emma Aneheim|Last update: 4/8/2011
Share:

The University of Gothenburg uses cookies to provide you with the best possible user experience. By continuing on this website, you approve of our use of cookies.  What are cookies?